Pathological stainings also showed that the expressions of fibrotic markers (α‐SMA, VIM, and EN1) were significantly downregulated in the skin tissues of scleroderma mice after EM organoid treatment (Figure 3d,e). The gene discussed is EN1; the disease is erythema multiforme.